Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Post-market, prospective, non randomized, open label, multicentre, clinical study analysing outcomes of shoulder arthroplasty with SMR TT Hybrid Glenoid with or without SMR Cementless Finned Short Stem
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SMR TT Hybrid Glenoid without Cementless Finned Short Stem | Patients implanted with SMR TT Hybrid Glenoid without Cementless Finned Short Stem |
| |
| SMR TT Hybrid Glenoid with Cementless Finned Short Stem | Patients implanted with SMR TT Hybrid Glenoid with Cementless Finned Short Stem |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SMR TT Hybrid Glenoid without Cementless Finned Short Stem | Device | The subject SMR Hybrid Glenoid System and SMR cementless finned short stem is intended for both primary or revision anatomic and reverse shoulder joint replacement. The glenoid components when used as part of an anatomic shoulder replacement are intended for cemented fixation. |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of patients reaching a clinical progression from baseline to 24-month follow-up | The primary endpoint consists of the proportion of patients reaching a clinical progression from baseline to 24-month follow-up measured as:
| 24 Months |
| Measure | Description | Time Frame |
|---|---|---|
| Measure American Shoulder and Elbow Surgeons Shoulder Score (ASES) | The ASES questionnaire is composed of both a physician-rated component and a patient-reported component. The patient questions focus on joint pain, instability, and activities of daily living. Scores range from 0 to 100 with a score of 0 indicating a worse shoulder condition and 100 indicating a better shoulder condition. | Baseline to 24 and 60 Months |
Not provided
Inclusion Criteria:(Key)
Both genders;
Age ≥ 18 years old;
Full skeletal maturity;
Life expectancy over 5 years;
Patient is requiring primary unilateral arthroplasty based on physical examination and medical history;
Good bone quality evaluated by the Investigator and the intraoperative evaluation;
A diagnosis in the target shoulder of one or more of the S-11 SMR TT Hybrid Glenoid and Cementless Finned Short Stem Version Sep 2021 2.0 Confidential Page11 following:
Exclusion Criteria (Key):
These are key eligibility criteria, other eligibility criteria apply.
Not provided
Not provided
Not provided
Orthopedic Clinics
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Laura Sanchez | Contact | 817-233-1686 | laura.sanchez@limacorporate.com | |
| Ryan Bacchus | Contact | 817-233-1686 | ryan.bacchus@limacorporate.com |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| SMR TT Hybrid Glenoid with Cementless Finned Short Stem | Device | The subject SMR Hybrid Glenoid System and SMR cementless finned short stem is intended for both primary or revision anatomic and reverse shoulder joint replacement. The glenoid components when used as part of an anatomic shoulder replacement are intended for cemented fixation. The fins are intended to enhance press-fit fixation. The same proximal morse taper is used for coupling to the same humeral bodies in the SMR Shoulder System. The SMR finned short stem is intended for cementless fixation. |
|
| Measure Oxford shoulder score | Oxford Shoulder Score (OSS) is a 12-item patient-reported PRO specifically designed and developed for assessing outcomes of shoulder surgery. | Baseline to 24 and 60 Months |
| Measure Constant Score | The Constant-Murley score (CMS) is a 100-points scale composed of a number of individual parameters. These parameters define the level of pain and the ability to carry out the normal daily activities of the patient. The higher the score, the higher the quality of the function. | Baseline to 24 and 60 Months |
| Measure Simple Shoulder Test | Simple Shoulder Test (SST) is a series of 12 "yes" or "no" questions the patient answers about the function of the involved shoulder. The answers to these questions provides a standardized way of recording the function of a shoulder before and after treatment. The difference between the shoulder function before treatment and after the recovery period is the effectiveness of the treatment. | Baseline to 24 and 60 Months |
| Measure Patient Satisfaction | The satisfaction of the patients with regard to the effectiveness of the prosthetic treatment is graded on a scale from 1 to 5 | Baseline to 24 and 60 Months |
| Stability of the SMR TT hybrid glenoid component with or without SMR cementless finned short stem | Rate of symptomatic radiolucent lines, loosening and subsidence ≥2 mm | Immediately postoperative to 24 Months |
| System conversion rate, intended as a conversion within the SMR system from anatomic to reverse | The SMR shoulder system is a modular system and in case of evolution of the pathology it may be easily converted from one configuration to another. | 24 Months |
| Failure rate, intended as removal of the SMR TT hybrid glenoid component | A removal of the glenoid component is intended as a revision and a failure of the implant. | Immediately postoperative to 24 Months |
| Failure rate, intended as removal of the SMR cementless finned short stem | A removal of the stem component is intended as a revision and a failure of the implant. | Immediately postoperative to 24 Months |
| Incidence of device-related AE/SAE (ADE/SADE) | Device Related Adverse Events/Serious Adverse Events, device deficiencies, malfunctions and use errors at all follow-up time points | Immediately postoperative to 24 and 60 Months |
| Survival rate (Kaplan-Meier) | 60 Months |
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| D001172 | Arthritis, Rheumatoid |
| D010020 | Osteonecrosis |
| D006810 | Humeral Fractures |
| D000070656 | Rotator Cuff Tear Arthropathy |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D001847 | Bone Diseases |
| D009336 | Necrosis |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001134 | Arm Injuries |
| D014947 | Wounds and Injuries |
| D050723 | Fractures, Bone |
| D002805 | Chondrocalcinosis |
| D000070657 | Crystal Arthropathies |
Not provided
Not provided